PRESS RELEASE published on 09/02/2025 at 09:22, 1 year 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA issued a declaration regarding the number of shares and voting rights. Total shares: 97,330,405. Total voting rights: 165,544,375 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech SA
BRIEF published on 08/04/2025 at 10:55, 1 year 2 months ago Sartorius Stedim Biotech: Number of shares and voting rights Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 08/04/2025 at 10:50, 1 year 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA: Declaration of the number of shares and voting rights in the issued capital as of July 31, 2025 Voting Rights Déclaration Shares Sartorius Stedim Biotech Issued Capital
BRIEF published on 07/22/2025 at 07:07, 1 year 3 months ago Sartorius Stedim Biotech Releases H1 2025 Financial Report Business Development Biopharmaceutical Industry Half-year Results Sartorius Stedim 2025 Financial Report
BRIEF published on 07/22/2025 at 07:05, 1 year 3 months ago Sartorius Stedim Biotech Reports Solid Half-Year 2025 Results Profitability Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry Half-year Results 2025
PRESS RELEASE published on 07/22/2025 at 07:02, 1 year 3 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases first half 2025 results and full year forecast. Report available online with financial statements and company profile Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry First Half 2025 Results
PRESS RELEASE published on 07/22/2025 at 07:00, 1 year 3 months ago Half-year results 2025 of Sartorius Stedim Biotech Sartorius Stedim Biotech reports strong half-year results for 2025 with sales revenue up 9.4% in constant currencies and underlying EBITDA rising by 19.3% Sartorius Stedim Biotech Sales Revenue Half-year Results 2025 Underlying EBITDA
BRIEF published on 07/03/2025 at 10:04, 1 year 3 months ago Sartorius Stedim Biotech SA: Share and Voting Rights Declaration Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
BRIEF published on 07/03/2025 at 10:03, 1 year 3 months ago Sartorius Stedim Biotech Half-Year Liquidity Contract Update Liquidity Shares Market Practice Buy-Sell Trade Volume
PRESS RELEASE published on 07/03/2025 at 09:59, 1 year 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital per regulatory requirements Voting Rights Capital Shares Sartorius Stedim Biotech SA Regulatory Requirements
Published on 10/30/2026 at 23:35, 1 day 4 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 4 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 8 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 12 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 11 hours 6 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 4 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 9 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 4 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 15 hours ago Capital increase through exercise of subscription rights
